| ChEMBL: towards direct deposition of bioassay data D Mendez, A Gaulton, AP Bento, J Chambers, M De Veij, E Félix, ... Nucleic acids research 47 (D1), D930-D940, 2019 | 1935 | 2019 |
| Genetic drug target validation using Mendelian randomisation AF Schmidt, C Finan, M Gordillo-Marañón, FW Asselbergs, DF Freitag, ... Nature communications 11 (1), 3255, 2020 | 352 | 2020 |
| Therapeutic targets for heart failure identified using proteomics and Mendelian randomization A Henry, M Gordillo-Marañón, C Finan, AF Schmidt, JP Ferreira, R Karra, ... Circulation 145 (16), 1205-1217, 2022 | 113 | 2022 |
| Marketing authorization applications made to the European medicines agency in 2018–2019: what was the contribution of real‐world evidence? R Flynn, K Plueschke, C Quinten, V Strassmann, RG Duijnhoven, ... Clinical Pharmacology & Therapeutics 111 (1), 90-97, 2022 | 109 | 2022 |
| Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease AF Schmidt, NB Hunt, M Gordillo-Marañón, P Charoen, F Drenos, ... Nature communications 12 (1), 5640, 2021 | 105 | 2021 |
| Safety Monitoring of COVID‐19 Vaccines: Perspective from the European Medicines Agency J Durand, JM Dogné, C Cohet, K Browne, M Gordillo‐Marañón, L Piccolo, ... Clinical Pharmacology & Therapeutics 113 (6), 1223-1234, 2023 | 29 | 2023 |
| Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics M Gordillo-Marañón, M Zwierzyna, P Charoen, F Drenos, S Chopade, ... Nature communications 12 (1), 6120, 2021 | 24 | 2021 |
| Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes AF Schmidt, R Joshi, M Gordillo-Marañón, F Drenos, P Charoen, ... Communications medicine 3 (1), 9, 2023 | 19 | 2023 |
| Comparing the effects of CETP in East Asian and European ancestries: a Mendelian randomization study D Dunca, S Chopade, M Gordillo-Marañón, AD Hingorani, ... Nature Communications 15 (1), 5302, 2024 | 7 | 2024 |
| COVID-19 Vaccines and Heavy Menstrual Bleeding: The Impact of Media Attention on Reporting to EudraVigilance M Gordillo-Marañón, A Szmigiel, V Yalmanová, I Caplanusi, G Genov, ... Drug Safety, 1-16, 2024 | 3 | 2024 |
| Lessons Learned on Observed-to-Expected Analysis Using Spontaneous Reports During Mass Vaccination M Gordillo-Marañón, G Candore, K Hedenmalm, K Browne, R Flynn, ... Drug Safety, 1-9, 2024 | 3 | 2024 |
| Genetic risk and incident venous thromboembolism in middle-aged and older adults following 1 Covid-19 vaccination DPA J Xie, A Prats-Uribe, M Gordillo-Marañón,VY. Strauss, D Gill Journal of Thrombosis and Haemostasis, 1-9, 2022 | 3* | 2022 |
| Reevaluating the pathogenicity of the mutation c. 1194+ 5 G> A in GAA gene by functional analysis of RNA in a 61-year-old woman diagnosed with Pompe disease by muscle biopsy C Amiñoso, M Gordillo-Marañón, J Hernández, J Solera Neuromuscular Disorders 29 (3), 187-191, 2019 | 2 | 2019 |
| Effect of genetically predicted sclerostin on cardiovascular biomarkers, risk factors, and disease outcomes M Alcalde-Herraiz, JQ Xie, D Newby, C Prats, D Gill, M Gordillo-Marañón, ... Nature communications 15 (1), 9832, 2024 | 1 | 2024 |
| Disease coverage of human genome-wide association studies and pharmaceutical research and development M Gordillo-Marañón, AF Schmidt, A Warwick, C Tomlinson, C Ytsma, ... Communications Medicine 4 (1), 195, 2024 | 1 | 2024 |
| Harnessing confounding and genetic pleiotropy to identify causes of disease through proteomics and Mendelian randomisation–‘MR Fish’ AN Warwick, AD Hingorani, AP Khawaja, M Gordillo-Marañón, ... medRxiv, 2024.07. 11.24310200, 2024 | 1 | 2024 |
| Identification of Pregnancy Adverse Drug Reactions in Pharmacovigilance Reporting Systems: A Novel Algorithm Developed in EudraVigilance C Zaccaria, L Piccolo, M Gordillo-Marañón, G Touraille, C de Vries Drug Safety, 1-10, 2024 | 1 | 2024 |
| Comparing the effect profile of CETP in individuals of East Asian and European ancestries D Dunca, S Chopade, M Gordillo-Marañón, AD Hingorani, ... medRxiv, 2023.05. 26.23290616, 2023 | 1 | 2023 |
| Predicting the submission frequency of periodic safety update reports: development and application of the EURD tool M Gordillo-Marañón, G Candore, M López-Fauqued, KC Deli, L Piccolo, ... Frontiers in Medicine 11, 1299190, 2024 | | 2024 |
| Comparing the drug target effects profile of Cholesteryl ester transfer protein (CETP) between East-Asian and European ancestries D Dunca, S Chopade, M Gordillo-Maranon, A Hingorani, K Kuchenbacker, ... EUROPEAN JOURNAL OF HUMAN GENETICS 32, 417-417, 2024 | | 2024 |
